Tempus Announces Leadership Team Expansion Including Chief Commercial Officer and Chief Financial Officer

NEWS

July 8, 2021

Tempus, a leader in artificial intelligence and precision medicine, today announced the addition of six new hires to the leadership team, including a new Chief Commercial Officer, Chief Financial Officer, General Counsel, and the company’s first Chief Accounting Officer, Senior Vice President of Marketing, and Senior Vice President of Corporate Development. 

“In the last year, we were fortunate enough to accelerate Tempus’ growth into new disease areas and products. We continue to assemble a top-tier leadership team to shepherd our efforts, and we are thrilled to have some of the leading experts in their respective fields join us in our endeavor to bring AI and precision medicine to healthcare,” said Eric Lefkofsky, Founder and CEO of Tempus.

Chief Commercial Officer

Terron Bruner serves as Tempus’ Chief Commercial Officer, where he is responsible for the company’s commercialization strategy and sales functions. Prior to joining Tempus, Bruner held various leadership roles at Amazon Web Services (AWS), most recently leading Sales for AWS’ Global Healthcare and Life Sciences business. At AWS, he was responsible for building and scaling world-class teams that drove innovation, delivered exponential revenue growth, and engaged deeply with genomic, pharma, and healthcare technology customers. 

Chief Financial Officer

As Chief Financial Officer, Jim Rogers oversees the accounting, financial planning and analysis (FP&A), treasury, and investor relations functions. He joined Tempus’ finance team in 2017 after holding various positions at Groupon over the course of six years, including leading FP&A for the North America business and serving as the financial controller of the Asia Pacific operations. Prior to Groupon, Rogers was part of Ernst & Young’s assurance practice, where he worked with various financial services firms. 

Chief Accounting Officer

Ryan Bartolucci is Tempus’ Chief Accounting Officer. Before Tempus, he was at Surgalign Spine (f/k/a RTI Surgical), a medical device manufacturer and distributor, in the same role where he was responsible for public company accounting activities, internal controls, and external audit coordination. Bartolucci was also the Corporate Controller at Sagent Pharmaceuticals after spending eleven years at PricewaterhouseCoopers LLP.

General Counsel

Andy Polovin serves as General Counsel and is responsible for the company’s legal and business issues. Prior to joining Tempus, Polovin was the General Counsel of Uptake Technologies, Inc., a company specializing in artificial intelligence software for heavy industry. He has also served as an Assistant United States Attorney focusing on narcotics and white-collar crime investigations, an equity partner at Bartlit Beck, one of the nation’s leading trial boutiques, and a Law Clerk to the Chief Judge of the U.S. Court of Appeals for the Seventh Circuit. 

Senior Vice President, Marketing

Tempus’ new Senior Vice President of Marketing is Patty Spiller, who oversees the marketing and communications strategy and functions. Most recently, Spiller was the Vice President of Growth Marketing at Livongo/Teladoc, a global leader in whole person virtual care, where she founded and scaled the Growth Marketing team that drove innovation and generated significant growth. After Livongo’s merger with Teladoc, she led the Growth Marketing team for the combined company. Prior to Livongo, Spiller held various marketing leadership roles at Abbott, launching innovative technologies globally. 

Senior Vice President, Head of Corporate Development

Christina Antoniou serves as Senior Vice President, Head of Corporate Development at Tempus, where she is responsible for the company’s mergers, acquisitions, partnerships, and strategic investing efforts. Before joining Tempus, Antoniou spent four years at Medidata Solutions, a Dassault Systèmes company. There, she held multiple roles, including Vice President, Head of Integration and Senior Director, Corporate Development, completing several strategic acquisitions and early-stage investments. Later, she represented Medidata in its sales process, culminating in the sale of Medidata to Dassault Systèmes for $5.8 billion. Earlier in her career,  Antoniou held roles in investment banking and venture capital. 

About Tempus

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make real-time, data-driven decisions to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com